Teladoc Health, Inc. (NYSE:TDOC) Receives $9.81 Average Price Target from Analysts

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has been given an average rating of "Hold" by the nineteen brokerages that are presently covering the stock, MarketBeat.com reports. Twelve investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $9.71.

A number of equities research analysts have weighed in on the stock. Wells Fargo & Company cut their price objective on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a report on Thursday. Evercore ISI lowered their price objective on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a research report on Thursday, May 1st. Bank of America lowered their price objective on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. Stifel Nicolaus lowered their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research report on Thursday, May 1st. Finally, Oppenheimer lowered their price objective on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th.

Teladoc Health Trading Up 3.1%

NYSE:TDOC traded up $0.22 during trading hours on Wednesday, reaching $7.33. The company's stock had a trading volume of 1,022,298 shares, compared to its average volume of 6,231,763. The firm has a 50-day simple moving average of $7.75 and a 200-day simple moving average of $9.42. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of -1.27 and a beta of 1.82. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Research analysts expect that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.58% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TDOC. Point72 Asset Management L.P. grew its position in Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after acquiring an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. lifted its stake in Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after purchasing an additional 2,331,000 shares during the last quarter. Two Sigma Investments LP bought a new stake in Teladoc Health in the fourth quarter worth about $18,348,000. Two Sigma Advisers LP lifted its stake in Teladoc Health by 213.0% in the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock worth $20,532,000 after purchasing an additional 1,537,094 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in Teladoc Health by 7.0% in the first quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock worth $157,229,000 after purchasing an additional 1,289,183 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.